I decided to put together some extensive information, research and strategies consumers can use to get access to GLP-1 medications.
I think this educational information is important considering:
- The full retail cost of GLP-1 medications can come to more than $16,000 per year
- Adoption of GLP-1 medications like Wegovy / Ozempic has grown exponentially over the last 5 years
- The cost of GLP-1s are 10X more expensive in the USA than other countries
- Access to GLP-1s in the USA via insurance / medicare can be very difficult.
Furthermore, this week the Centers for Medicare & Medicaid Services said did not move forward with a proposal put forth by the Biden administration for Medicare coverage of weight-loss drugs such as Novo Nordisk's Wegovy.
Given there are an estimated 40 million people taking GLP-1 medications globally and tens of millions of additional people want access to these medications I think this educational information is important. I pulled information from over 100 sources for this article and summarized my findings. This article is for informational purposes only and does not constitute medical or legal advice. Consult with healthcare providers and insurance professionals regarding your specific situation.
Part 1 - The Rise of GLP-1 Medications in the United States: Adoption, Usage, and Economic Impact
Part 2 - Why are GLP-1 Medications 10X More Expensive in the USA than the Rest of the World? Who Pays for the Most Prescribed Medications in America?
Part 3 - Strategies for Getting Insurance Coverage for GLP-1 Medications - Best Practices for US Consumers
Part 4 - Accessing GLP-1 Medications on Medicaid and Medicare
This information is available on our on our podcast in four short episodes. (Free - no login needed) https://glp1tribe.com/podcast
You can also read the full article here:
https://glp1tribe.com/blog/glp-1-medication-access-insurance-coverage
(No login needed, no ads - It was too long to post the full article here.